期刊
BIORESOURCES AND BIOPROCESSING
卷 6, 期 -, 页码 -出版社
SPRINGER HEIDELBERG
DOI: 10.1186/s40643-019-0256-6
关键词
Cytochrome P450s (CYPs); Squalene-type triterpenoids (STs); Saccharomyces cerevisiae; Ganoderma lucidum; Synthetic biology
资金
- National Natural Science Foundation of China [31600071]
- Shanghai Municipal Natural Science Foundation [17ZR1448900, 18ZR1420300]
Background: Squalene-type triterpenoids (STs) are a class of linearized triterpenoids with significant bioactivities, including anti-cancer, anti-oxidative, and anti-inflammatory activities. The efficient biosynthesis of STs has gained increasing attention. Results: Using Saccharomyces cerevisiae as a heterologous host, we discovered that overexpression of CYP505D13 from Ganoderma lucidum, a famous medicinal mushroom capable of producing various triterpenoids as secondary metabolites, enables the engineered S. cerevisiae strain to produce two new STs, 4,8-dihydroxy-22,23-oxidosqualene (ST-1), 8-hydroxy-2,3;22,23-squalene dioxide (ST-2), and a known ST, 2,3; 22,23-squalene dioxide (ST-3), at the respective titers of 3.28 mg/L, 13.77 mg/L, and 12.23 mg/L after 59 h fermentation. Furthermore, our in vitro enzymatic assay implies that CYP505D13 is involved in the formation of ST-3. Conclusions: This study provides a promising alternative to discover STs and facilitate their efficient bioproduction.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据